November 22, 2016 - By Nellie Frank · 0 Comments
Wafergen Bio-systems Inc (NASDAQ:WGBS) institutional sentiment increased to 2.25 in Q2 2016. Its up 1.25, from 1 in 2016Q1. The ratio increased, as 9 hedge funds increased and opened new stock positions, while 9 sold and decreased their holdings in Wafergen Bio-systems Inc. The hedge funds in our partner’s database now hold: 2.04 million shares, down from 2.15 million shares in 2016Q1. Also, the number of hedge funds holding Wafergen Bio-systems Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 6 Reduced: 3 Increased: 4 New Position: 5.
WaferGen Bio-systems, Inc. is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The company has a market cap of $17.52 million. The Firm focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. It currently has negative earnings. The Company’s ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS).
The stock closed at $0.911 during the last session. It is down 62.50% since April 20, 2016 and is uptrending. It has outperformed by 57.94% the S&P500.
According to Zacks Investment Research, “WaferGen Biosystems, Inc., a development stage company, engages in the development, manufacture, and sale of systems for gene expression, genotyping, and stem cell research for the life sciences, pharmaceutical industries, biomarker discovery and diagnostic products industries. The company is actively developing its SmartChip(TM) product for the gene expression and genotyping markets. This innovative system, combined with next-generation chemistry and optimized assays being developed by WaferGen, promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets. It offers SmartSlide Micro-Incubation system that provides a controlled environment and physiological conditions for imaging studies, allowing researchers to characterize, differentiate, and proliferate various cells. WaferGen’s revolutionary systems are the first of their kind, providing researchers with critical performance advantages that are not available with existing technologies.”
Sabby Management Llc holds 0.08% of its portfolio in WaferGen Bio-systems, Inc. for 1.87 million shares. Two Sigma Securities Llc owns 32,674 shares or 0.01% of their US portfolio. Moreover, Bank Of America Corp De has 0% invested in the company for 2,537 shares. The California-based Blackrock Fund Advisors has invested 0% in the stock. Citadel Advisors Llc, a Illinois-based fund reported 11,459 shares.#img1#
WaferGen Bio-systems, Inc. (WaferGen), incorporated on August 4, 2005, is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Firm focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company’s ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company’s SmartChip platform, which is also used for profiling and validating molecular biomarkers.
More notable recent WaferGen Bio-systems, Inc. (NASDAQ:WGBS) news were published by: Prnewswire.com which released: “WaferGen Bio-systems Reports Results for Third Quarter 2016” on November 08, 2016, also Prnewswire.com with their article: “WaferGen Bio-systems Reports Strong Revenue Growth in Third Quarter of 2016” published on October 31, 2016, Prnewswire.com published: “WaferGen Bio-systems and Takara Bio Inc. Announce Merger Agreement” on May 13, 2016. More interesting news about WaferGen Bio-systems, Inc. (NASDAQ:WGBS) were released by: Quotes.Wsj.com and their article: “News WaferGen Bio-Systems Inc.WGBS” published on June 08, 2011 as well as Prnewswire.com‘s news article titled: “WaferGen Bio-systems Announces Adjournment of Special Meeting of Stockholders” with publication date: October 26, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Nellie Frank